Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fennec Pharmaceuticals (FENC) Equity Ratio: 2011-2025

Historic Equity Ratio for Fennec Pharmaceuticals (FENC) over the last 15 years, with Sep 2025 value amounting to -0.09.

  • Fennec Pharmaceuticals' Equity Ratio fell 3.90% to -0.09 in Q3 2025 from the same period last year, while for Sep 2025 it was -0.09, marking a year-over-year decrease of 3.90%. This contributed to the annual value of -0.13 for FY2024, which is 69.80% up from last year.
  • Fennec Pharmaceuticals' Equity Ratio amounted to -0.09 in Q3 2025, which was up 45.17% from -0.17 recorded in Q2 2025.
  • In the past 5 years, Fennec Pharmaceuticals' Equity Ratio ranged from a high of 0.90 in Q1 2021 and a low of -0.50 during Q2 2023.
  • Moreover, its 3-year median value for Equity Ratio was -0.13 (2025), whereas its average is -0.12.
  • Per our database at Business Quant, Fennec Pharmaceuticals' Equity Ratio spiked by 420.60% in 2023 and then crashed by 674.05% in 2025.
  • Over the past 5 years, Fennec Pharmaceuticals' Equity Ratio (Quarterly) stood at 0.73 in 2021, then tumbled by 87.40% to -0.10 in 2022, then tumbled by 353.66% to -0.43 in 2023, then soared by 69.80% to -0.13 in 2024, then declined by 3.90% to -0.09 in 2025.
  • Its Equity Ratio was -0.09 in Q3 2025, compared to -0.17 in Q2 2025 and -0.13 in Q1 2025.